FGHQ.F Stock Overview
A contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Frontage Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.10 |
| 52 Week High | HK$0.16 |
| 52 Week Low | HK$0.10 |
| Beta | 0.84 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -79.39% |
Recent News & Updates
Recent updates
Shareholder Returns
| FGHQ.F | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | 0% | -1.9% | -2.2% |
| 1Y | n/a | -5.3% | 23.9% |
Return vs Industry: Insufficient data to determine how FGHQ.F performed against the US Life Sciences industry.
Return vs Market: Insufficient data to determine how FGHQ.F performed against the US Market.
Price Volatility
| FGHQ.F volatility | |
|---|---|
| FGHQ.F Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 9.2% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 17.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: FGHQ.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine FGHQ.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 1,657 | Abdul Mutlib | www.frontagelab.com |
Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies. It offers laboratory testing services, such as method development and validation, and sample analysis and central laboratory services; chemistry, manufacturing, and control services, including assistance in drug product development and analysis, and delivery and supply of clinical trial materials; and drug metabolism and pharmacokinetic services. The company also provides early stage clinical/bioequivalence services; absolute bioavailability and human radiolabel studies; and chemistry services, including performing custom synthesis.
Frontage Holdings Corporation Fundamentals Summary
| FGHQ.F fundamental statistics | |
|---|---|
| Market cap | US$158.39m |
| Earnings (TTM) | US$6.10m |
| Revenue (TTM) | US$259.97m |
26.0x
P/E Ratio0.6x
P/S RatioIs FGHQ.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FGHQ.F income statement (TTM) | |
|---|---|
| Revenue | US$259.97m |
| Cost of Revenue | US$185.73m |
| Gross Profit | US$74.25m |
| Other Expenses | US$68.15m |
| Earnings | US$6.10m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.003 |
| Gross Margin | 28.56% |
| Net Profit Margin | 2.35% |
| Debt/Equity Ratio | 28.5% |
How did FGHQ.F perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/09/18 11:56 |
| End of Day Share Price | 2024/06/21 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Frontage Holdings Corporation is covered by 10 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bo Li | BofA Global Research |
| Bo Li | CLSA |
| Ziyi Chen | Goldman Sachs |